Copyright
©The Author(s) 2015.
World J Hepatol. Apr 8, 2015; 7(4): 710-716
Published online Apr 8, 2015. doi: 10.4254/wjh.v7.i4.710
Published online Apr 8, 2015. doi: 10.4254/wjh.v7.i4.710
Etiological agent | Outcome | Duration ofbacteremia (d) | Treatment | Duration of treatment (wk) | Cirrhosis etiology | Onset (d) | Ref. |
Gram positive, monomicrobial infections | |||||||
Staphylococcus aureus | R | 6 | Vancomycin Rifampin | 6 | EtOH | 110 | [3] |
Tx | - | - | - | HCV | 38 | [17] | |
D | 15 | Ciprofloxacin Penicillin Vancomycin Teicoplanin Rifampin | 9 | HCV | 8 | [6] | |
D | - | Flucloxacillin | 2 | EtOH | 663 | [2] | |
D | 5 | Vancomycin | 1 | EtOH, HBV, HCV | 100 | [18] | |
D | - | - | - | HCV | 38 | [17] | |
Staphylococcus aureus (MRSA) | R | 46 | Vancomycin Linezolid | 6 | Cryptogenic | 300 | [5] |
Staphylococcus epidermidis | R | 25 | Daptomycin | 6 | EtOH | 7 | [19] |
R | 30 | Vancomycin | 6 | EtOH | 120 | [5] | |
Enterococcus spp. (unspecified) | R | 14 | Vancomycin | 6 | Cryptogenic | 47 | [5] |
R | 10 | Vancomycin Gentamicin | 28 | EtOH, HCV | 10 | [20] | |
R | 3 | Vancomycin Gentamicin | 2 | EtOH | 60 | [18] | |
R | 21 | Vancomycin | 7 | HCV | - | [20] | |
D | - | Vancomycin | - | EtOH | 60 | [20] | |
Tx | - | - | - | HCV | 38 | [20] | |
D | - | - | - | HCV | 38 | [20] | |
D | - | - | - | HCV | 38 | [20] | |
Enterococcus faecalis | R | 90 | Gentamicin Amphotericin | 6 | EtOH | 420 | [21] |
R | 100 | Quinupristin | 14 | Cryptogenic | - | [22] | |
R | 10 | Vancomycin | 8 | Cryptogenic | 60 | [23] | |
Tx | 10 | Vancomycin | 4 | Cryptogenic | 90 | [16] | |
Enterococcus faecium | R | 10 | Vancomycin | 28 | EtOH | 10 | [20] |
- | - | Vancomycin | 1 | EtOH | 375 | [2] | |
Streptococcus sanguis | R | 6 | Penicillin | 4 | EtOH | 416 | [3] |
Gemella morbillorum | R | 5 | Vancomycin | 2 | PSC | 6 | [18] |
R | 60 | Ampicillin | 44 | EtOH | 56 | [24] | |
Streptococcus bovis | R | 6 | Vancomycin | 6 | Cryptogenic | 416 | [3] |
Lactobacillus rhamnosus | R | - | Netilmicin, Clarithromycin | 12 | EtOH | 730 | [2] |
Lactobacillus acidophillus | D | 4 | Ampicillin | 4 | EtOH | 732 | [18] |
D | 3 | Ampicillin Gentamicin | 6 | EtOH | 146 | [18] | |
Gram negative, monomicrobial infections | |||||||
Escherichia coli | R | 6 | Ceftriaxone | 4 | EtOH | 183 | [3] |
R | 6 | Ceftriaxone | 4 | EtOH | 532 | [3] | |
R | 31 | Ciprofloxacin | 16 | EtOH | 1065 | [6] | |
D | - | Ceftriaxone | 12 | EtOH | 282 | [2] | |
Gentamicin | |||||||
D | - | Ceftriaxone Vancomycin Piperacillin-Tazobactam Amoxicillin | 12 | EtOH | 1092 | [2] | |
D | - | Meropenem Amikacin | 3 | EtOH | 765 | [2] | |
Klebsiella pneumonia | R | 6 | Ceftriaxone | 4 | EtOH, HCV | 329 | [3] |
Klebsiella (unspecified) MDR | R | 9 | Tigecycline | - | EtOH | 1095 | [25] |
Serratia marcescens | R | 49 | Imipenem | 98 | EtOH | 21 | [26] |
Enterobacter cloacae | R | - | Ceftriaxone Gentamicin Vancomycin Piperacillin-Tazobactam Meropenem Ciprofloxacin | 12 | EtOH | 1065 | [2] |
Salmonella typhi | - | - | - | - | - | - | [27] |
Fungal infections | |||||||
Candida glabrata | R | 1700 | Amphotericin | 51 | HCV | 180 | [28] |
D | 27 | Amphotericin | 27 | Cryptogenic | 27 | [29] | |
D | - | Fluconazole | - | EtOH | 150 | [30] | |
D | 60 | Posaconazole | 6 | EtOH | - | [31] | |
Candida albicans | R | - | - | - | HBV | 38 | [18] |
D | - | - | - | HCV | 38 | [18] | |
Polymicrobial infections | |||||||
Staphylococcus aureus/Pseudomonas aeruginosa | D | 14 | Ticarcillin-clavulanic acid Gentamicin Amikacin Ciprofloxacin | - | EtOH, HBV | 35 | [6] |
Escherichia coli/Klebsiella oxytoca | R | 6 | Ceftriaxone | 4 | EtOH | 235 | [3] |
Escherichia coli/Acinetobacter | R | 6 | Ceftriaxone | 6 | EtOH | 285 | [3] |
Escherichia coli/Klebsiella oxytoca | R | 6 | Piperacillin-Tazobactam Gentamicin | 6 | Cryptogenic, EtOH | 1158 | - |
“Polymicrobial” | R | 720 | - | 101 | HCV | 100 | [32] |
“Polymicrobial” | Tx | 90 | - | - | HCV | 180 | [15] |
Unknown | - | - | - | - | - | - | [2] |
- Citation: Navaratnam AM, Grant M, Banach DB. Endotipsitis: A case report with a literature review on an emerging prosthetic related infection. World J Hepatol 2015; 7(4): 710-716
- URL: https://www.wjgnet.com/1948-5182/full/v7/i4/710.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i4.710